Education
About Us
Working with TipRanks
Follow Us
MYND Life Sciences (TSE:MYND)
:MYND
Total Valuation
MYND Life Sciences has a market cap or net worth of C$3.35M. The enterprise value is C$4.85M.
Market CapC$3.35M
Enterprise ValueC$4.85M
Share Statistics
MYND Life Sciences has 47,817,180 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding47,817,180
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
MYND Life Sciences’s return on equity (ROE) is 0.30 and return on invested capital (ROIC) is 91.43%.
Return on Equity (ROE)0.30
Return on Assets (ROA)-1.90
Return on Invested Capital (ROIC)91.43%
Return on Capital Employed (ROCE)0.36
Revenue Per Employee―
Profits Per Employee-10.00T>
Employee Count―
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of MYND Life Sciences is ―. MYND Life Sciences’s PEG ratio is 0.00806.
PE Ratio―
PS Ratio0.00
PB Ratio-0.14
Price to Fair Value-0.14
Price to FCF-3.58
Price to Operating Cash Flow-16.69
PEG Ratio0.00806
Income Statement
In the last 12 months, MYND Life Sciences had revenue of 0.00 and earned -1.52M in profits. Earnings per share was -0.03.
Revenue0.00
Gross Profit-332.99K
Operating Income-1.81M
Pretax Income-1.52M
Net Income-1.52M
EBITDA-1.83M
Earnings Per Share (EPS)-0.03
Cash Flow
In the last 12 months, operating cash flow was -172.78K and capital expenditures 0.00, giving a free cash flow of -172.78K billion.
Operating Cash Flow-172.78K
Free Cash Flow-172.78K
Free Cash Flow per Share>-0.01
Dividends & Yields
MYND Life Sciences pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.14
52-Week Price Change0.00%
50-Day Moving Average0.07
200-Day Moving Average0.07
Relative Strength Index (RSI)65.36
Average Volume (3m)0.00
Important Dates
MYND Life Sciences upcoming earnings date is Sep 25, 2025, After Close (Confirmed).
Last Earnings DateJun 26, 2025
Next Earnings DateSep 25, 2025
Ex-Dividend Date―
Financial Position
MYND Life Sciences as a current ratio of 0.14, with Debt / Equity ratio of -60.28%
Current Ratio0.14
Quick Ratio0.14
Debt to Market Cap4.23
Net Debt to EBITDA-1.64
Interest Coverage Ratio-2.48
Taxes
In the past 12 months, MYND Life Sciences has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
MYND Life Sciences EV to EBITDA ratio is -2.03, with an EV/FCF ratio of -18.71.
EV to Sales0.00
EV to EBITDA-2.03
EV to Free Cash Flow-18.71
EV to Operating Cash Flow-18.71
Balance Sheet
MYND Life Sciences has C$0.00 in cash and marketable securities with C$3.00M in debt, giving a net cash position of -C$3.00M billion.
Cash & Marketable SecuritiesC$0.00
Total DebtC$3.00M
Net Cash-C$3.00M
Net Cash Per Share-C$0.06
Tangible Book Value Per Share-C$0.11
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for MYND Life Sciences is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―